title: Pembrolizumab-induced polymyalgia rheumatica in two patients with metastatic melanoma.
authors.affiliation: Service de dermatologie, hôpital Cochin, Assistance publique-Hôpitaux de Paris, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France; Faculté de médecine, université Paris Descartes, 12, rue de l'École-de-Médecine, 75006 Paris, France.
authors.forename: Bethsabée
authors.initials: B
authors.lastname: Garel
authors.affiliation: Service de dermatologie, hôpital Cochin, Assistance publique-Hôpitaux de Paris, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France; Faculté de médecine, université Paris Descartes, 12, rue de l'École-de-Médecine, 75006 Paris, France. Electronic address: nora.kramkimel@aphp.fr.
authors.forename: Nora
authors.initials: N
authors.lastname: Kramkimel
authors.affiliation: Faculté de médecine, université Paris Descartes, 12, rue de l'École-de-Médecine, 75006 Paris, France; Service de rhumatologie, hôpital Cochin, Assistance publique-Hôpitaux de Paris, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
authors.forename: Anne-Priscille
authors.initials: AP
authors.lastname: Trouvin
authors.affiliation: Faculté de médecine, université Paris Descartes, 12, rue de l'École-de-Médecine, 75006 Paris, France; Service de rhumatologie, hôpital Cochin, Assistance publique-Hôpitaux de Paris, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
authors.forename: Camélia
authors.initials: C
authors.lastname: Frantz
authors.affiliation: Service de dermatologie, hôpital Cochin, Assistance publique-Hôpitaux de Paris, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France; Faculté de médecine, université Paris Descartes, 12, rue de l'École-de-Médecine, 75006 Paris, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Dupin
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D011111:Polymyalgia Rheumatica / Q000139:chemically induced* / Q000503:physiopathology; D035583:Rare Diseases; D018570:Risk Assessment; D012494:Sampling Studies; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C582435:pembrolizumab
keywords: Anti-PD-1 antibody; Melanoma; Pembrolizumab; Polymyalgia rheumatica